Post

New research · Nephrology
Kidney medicine · 4d
Cohort studyKidney medicine · 2026

Trajectories of Serum Total Carbon Dioxide and the Risk of Cardiorenal Outcomes in Chronic Kidney Disease: Results From the KNOW-CKD Study.

Semin Cho, Wookyung Chung, Young Youl Hyun … Ji Yong Jung
Read paper
NephrologyCohort study

Persistent low serum total carbon dioxide is associated with a higher hazard of renal events.

Trajectories of Serum Total Carbon Dioxide and the Risk of Cardiorenal Outcomes in Chronic Kidney Disease: Results From the KNOW-CKD Study.

Semin Cho … Ji Yong Jung
Kidney medicine · 2026
Background

Serum bicarbonate concentrations vary over time in chronic kidney disease (chronic kidney disease), but most studies have focused on baseline values rather than longitudinal trajectories.

Purpose

We aimed to determine the association between long-term patterns of serum total carbon dioxide (tCO 2 ) and adverse renal and cardiovascular outcomes.

Methods

With chronic kidney disease enrolled in a prospective cohort with repeated tCO 2 measurements.

HR, 2.08
Results
HR, 2.08
Persistently low blood carbon dioxide more than doubled the risk of kidney problems
More results

The High trajectory group showed a trend toward lower renal risk (HR, 0.57; 95% CI, 0.31-1.03), with time-dependent protective effects during prolonged follow-up.

The Improving group showed no significant differences in renal or cardiovascular risk but demonstrated a numerically lower incidence of the renal endpoint.

More results

Cardiovascular outcomes did not differ across trajectories.

LIMITATIONS: Observational design and potential residual confounding.

“
Conclusion · 1 of 2

Persistent low tCO 2 was associated with increased renal risk, whereas high levels conferred delayed protection. The Improving group showed intermediate risk.

Conclusion · 2 of 2

Longitudinal monitoring of tCO 2 may help guide individualized bicarbonate therapy in chronic kidney disease.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cohort Study
14.0%
About 1 in 7 survivors without prior risk factors had persistent kidney damage
Cohort Study
9.44
amyloid buildup increased the risk of needing kidney dialysis nine times
Cohort Study
3:54 vs. 4:41 h
recipients had shorter surgery time with the simultaneous robotic approach
Cohort Study
HR 4.00
Severe kidney scarring linked to about 4-fold higher rate of graft failure
Guideline
“This consensus aims to clarify for which patients renal denervation may be a viable therapeutic option, identify the main clinical and procedural considerations for its implementation, and promote its optimal and safe use through appropriate patient selection and multidisciplinary evaluation.”
Guideline
approximately 80%
how many people with early AL amyloidosis are expected to live for 5 years
Cohort Study
HR 2.144
Higher inflammatory index means more than double the risk of abdominal lining inflammation
Cohort Study
hazard ratio 4.00
high genetic risk and severe CKM syndrome meant a much higher risk of knee arthritis